RxDoctor Payments Data

David Struble, MD

Child & Adolescent Psychiatry · Memphis, TNNPI 1710919352

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,727in general payments, 2019–2025

Across 164 payments — averaging $22.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$668
  • AbbVie$638
  • Sunovion Pharmaceuticals Inc.$566
  • Johnson & Johnson$520
  • Otsuka America Pharmaceutical, Inc.$244
  • Neurocrine Biosciences, Inc.$201
  • plus $890 from 12 others

What the payments were for

  • Food & beverage$3,727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,727 in reported general payments places this provider in the 90th percentile of 43 child & adolescent psychiatry providers in Tennessee.

See all child & adolescent psychiatry providers in Tennessee

Medicare billing

Part B allowed, 2024
$67,782
Medicare patients
253
Services billed
1,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Paliperidone ErPaliperidone13$5,601
Carbamazepine ErCarbamazepine12$2,169
Bupropion XlBupropion Hcl19$212
Duloxetine Hcl11$191
Lamotrigine12$155
Topiramate18$154
Escitalopram Oxalate12$95
Trazodone Hcl12$75
Clonidine Hcl14$59
Metformin Hcl11$18

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Memphis

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →